Agyemang C, Bhopal R, Redekop WK. Does the pulse pressure in people of European, African and South Asian descent differ? A systematic review and meta-analysis of UK data. J Hum Hypertens 2007; 21: 598-609.
Van Baal PHM, Brouwer WBF, Hoogenveen RT, Feenstra TL. Increasing tobacco taxes: a cheap tool to increase public health. Health Policy 2007; 82: 142-152.
Van Baal PHM, Feenstra TL, Hoogenveen RT, De Wit GA, Brouwer WBF. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost-utility ratio. Health Econ 2007; 16: 421-433.
Baltussen R, Ten Asbroek AH, Koolman X, Shrestha N, Bhattarai P, Niessen LW. Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? Health Policy Plan 2007; 22: 178-185.
De Bont A, Zandwijken G, Stolk EA, Niessen LW. Prioritisation by physicians in the Netherlands: the growth hormone example in drug reimbursement decisions. Health Policy 2007; 80: 369-377.
Van den Bos GAM, Visser-Meily JMA, Van Exel NJA. Optimalisering van de zorg aan CVA-patiënten in de huisartsenpraktijk. Huisarts & Wetenschap 2007; 50: 552-556.
De Bree R, Van der Putten L, Hoekstra OS, Kuik DJ, Uyl-de Groot CA, Van Tinteren H, Leemans CR, Boers M. A randomized trial of PET scanning to improve diagnostic yield of direct laryngoscopy in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy. Contemp Clin Trials 2007; 28: 705-712.
De Bree R, Reith R, Quak JJ, Uyl-de Groot CA, Van Agthoven M, Leemans CR. Free radial forearm flap versus pectoralis major myocutaneous flap reconstruction of oral and oropharyngeal defects: a cost analysis. Clin Otolaryngol 2007; 32: 275-282.
Brouwer WBF, Van Exel NJA, Van Baal PHM. De kosten in gewonnen levensjaren: tijd voor een nieuwe richtlijn! VGE Infobulletin 2007; 24: 11-14.
Brouwer WBF, Van Exel NJA, Van Baal PHM, Polder JJ. Economics and public health: engaged to be happily married! Eur J Public Health 2007; 17: 122-123.
Cohen JP. The new Dutch health insurance system and its implications for pharmaceutical innovation.International Journal Pharmaceutical and Healthcare Marketing 2007; 1: 214-225.
Cohen JP, Faden L, Predaris S, Young B. Patient access to pharmaceuticals: an international comparison. Eur J Health Econ 2007; 8: 253-266.
Cohen JP, Paquette C, Cairns C. Can Medicare draw lessons from Dutch experience with a national formulary. Drug Inf J; 2007; 41: 257-272.
Cohen JP, Stolk EA, Niezen MGH. The increasingly complex fourth hurdle for pharmaceuticals.Pharmacoeconomics 2007; 25: 727-734.
Cuijpers P, Smit F, Oostenbrink JB, De Graaf R, Ten Have M, Beekman A. Economic costs of minor depression: a population-based study. Acta Psychiatr Scand 2007; 115: 229-236.
Essink-Bot ML, Stuifbergen MC, Meerding WJ, Looman CW, Bonsel GJ for the VOTE group (incl WBF Brouwer). Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study. BMC Health Serv Res 2007; 7: 62.
Van Exel NJA, Bobinac A, Koopmanschap MA, Brouwer WBF. Providing informal care: a burden and a blessing. Health and Ageing (Newsletter of the Geneva Association of Risk & Insurance Economics) 2007; 16: 10-13.
Van Exel NJA, De Graaf G, Brouwer WBF. Care for a break? An investigation of informal caregivers’ attitudes toward respite care using Q-methodology. Health Policy 2007; 83: 332-342.
Galani C, Schneider H, Rutten FFH. Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland. International Journal of Public Health 2007; 52: 1-11.
Goor KM, Peeters AJGE, Mahieu HF, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM, Van Agthoven M. Cordectomy by CO(2) laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck 2007; 29: 128-136.
Goossensen A, Zijlstra P, Koopmanschap MA. Measuring shared decision making processes in psychiatry: skills versus patient satisfaction. Patient Educ Couns 2007; 67: 50-56.
Gravelle H, Brouwer WBF, Niessen LW, Postma M, Rutten FFH. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ 2007; 16: 307-317.
Hakkaart-van Roijen L, Lamers LM, Bouwmans CAM, Van Straten A, Donker MCH. Comparison of EQ-5D and SF-6D in mental health patients. Journal of mental health policy and economics 2007; 10: S17.
Hakkaart-van Roijen L, Zwirs BW, Bouwmans CAM, Tan SS, Schulpen TW, Vlasveld L, Buitelaar JK. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 2007; 16: 316-326.
Hart HE, Redekop WK, Bilo HJG, Meyboom-de Jong B, Berg M. Health related quality of life in patients with type I diabetes mellitus: generic & disease-specific measurement. Indian J Med Res 2007; 125: 203-216.
Horn EK, Van Benthem TB, Hakkaart-van Roijen L, Van Marwijk HW, Beekman AT, Rutten FFH, Van der Feltz-Cornelis CM. Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial. BMC Health Serv Res 2007; 7: 28.
IJff MA, Huijbregts KM, Van Marwijk HW, Beekman AT, Hakkaart-van Roijen L, Rutten FFH, Unützer J, Van der Feltz-Cornelis CM. Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomised clinical trial. BMC Health Serv Res 2007; 7: 34.
Jansen E, Baltussen R, Van Doorslaer E, Ngirwamungu E, Nguyen MP, Kilima PM. An eye for inequality: how trachoma relates to poverty in Tanzania and Vietnam. Ophthalmic Epidemiol 2007; 14: 278-287.
Koopmanschap MA, Steenhoek A. Groter gebruik: lagere prijs. Kosten voor dure medicijnen rijzen de pan uit.Pharmaceutisch Weekblad 2007; 142: 21.
Krol M, Koopman M, Uyl-de Groot C, Punt CJA. A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer. Expert Opin Pharmacother 2007; 8: 1313-1328.
Lai T, Habicht J, Reinap M, Chisholm D, Baltussen R. Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in Estonia. Health Policy 2007; 84: 75-88.
Lamers LM. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Med Care 2007; 45: 238-244.
Lamers LM, Uyl-de Groot CA, Buijt I. The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scale. Pharmacoeconomics 2007; 25: 591-603.
Lintsen AME, Eijkemans MJC, Hunault CC, Bouwmans CAM, Hakkaart L, Habbema JDF, Braat DDM. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod 2007; 22: 2455-2462.
Luijsterburg PA, Lamers LM, Verhagen AP, Ostelo RW, Van den Hoogen HJ, Peul WC, Avezaat CJ, Koes BW. Cost-effectiveness of physical therapy and general practitioner care for sciatica. Spine 2007; 32: 1942-1948.
Niessen LW, Grijseels EWM, Koopmanschap MA, Rutten FFH. Economic analysis for clinical practice: the case of 31 national consensus guidelines in the Netherlands. J Eval Clin Pract 2007; 13: 68-78.
Niezen MGH, De Bont A, Stolk EA, Eyck A, Niessen LW, Stoevelaar HJ. Conditional reimbursement within the Dutch drug policy. Health Policy 2007; 84: 39-50.
Nijdam W, Levendag P, Fuller D, Schulz R, Prevost JB, Noever I, Uyl-de Groot CA. Robotic radiosurgery vs. brachytherapy as a boost to intensity modulated radiotherapy for tonsillar fossa and soft palate tumors: the clinical and economic impact of an emerging technology. Technol Cancer Res Treat 2007; 6: 611-620.
Polder JJ, Brouwer WBF. Een mistroostige wetenschap? TSG 2007; 85: 202-204.
Poley MJ, Edelenbos KI, Mosseveld M, Van Wijk MAM, De Bakker DH, Van der Lei J, Rutten-van Mölken MPMH. Cost consequences of implementing an electronic decision support system for ordering laboratory tests in primary care: evidence from a controlled prospective study in The Netherlands. Clin Chem 2007; 53: 213-219.
Rutten FFH, Brouwer WBF. Value for money in de zorg: geen woorden maar daden! M&O 2007: 171-179.
Rutten-van Mölken MPMH, Van Nooten FE, Lindemann M, Caeser M, Calverley PMA. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease. Pharmacoeconomics 2007; 25: 695-711.
Rutten-van Mölken MPMH, Oostenbrink JB, Miravitlles M, Monz BU. Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. Eur J Health Econ 2007; 8: 123-135.
Schandler M, Schwarz O, Hakkaart-van Roijen L, Jensen PS, Person U, Santosh P, Trott GE. Cost-effectiveness of ADHD treatment strategies in the international context: impact of therapeutic objective and comobidity. J Ment Health Policy Econ 2007; 10: S37.
Schandler M, Schwarz O, Hakkaart-van Roijen L, Jensen PS, Person U, Santosh P, Trott GE. Improving functional impairment in major life activities: cost-effectiveness of ADHD treatment strategies in the international context. J Ment Health Policy Econ 2007; 10: S38.
Sendi P, Brouwer WBF, Bucher HC, Weber R, Battegay M. When time is more than money: the allocation of time between work and leisure in HIV-infected patients. Soc Sci Med 2007; 64: 2355-2361.
Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJV. The economic burden of personality disorders. J Ment Health Policy Econ 2007; 10: S42.
Stalmeier PF, Lamers LM, Busschbach JJV, Krabbe PF. On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences. Med Care 2007; 45: 835-841.
Steinbusch PJM, Oostenbrink JB, Zuurbier JJ, Schaepkens FJM. The risk of upcoding in casemix systems: a comparative study. Health Policy 2007; 81: 289-299.
Tan SS, Uyl-de Groot CA, Huijgens PC, Fibbe WE. Stem cell transplantation in Europe: trends and prospects.Eur J Cancer 2007; 43: 2359-2365.